'Half-measure' virus vaccine intrigues experts
Evidence suggesting an initial half dose of the vaccine being developed by drugs firm AstraZeneca and the University of Oxford is more effective than a full dose is counterintuitive, and even took the researchers by surprise.
Nov 23, 2020
0
9